| Joshua Wallace French, MD | |
|
1025 New Moody Ln, La Grange, KY 40031-9154 | |
| (502) 222-5388 | |
| Not Available |
| Full Name | Joshua Wallace French |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Location | 1025 New Moody Ln, La Grange, Kentucky |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1275036238 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 57917 (Kentucky) | Primary |
| Entity Name | Southeastern Emergency Physicians Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1356379382 PECOS PAC ID: 2466364997 Enrollment ID: O20050302000285 |
News Archive
Mutations in a gene associated with leukaemia cause a newly described condition that affects growth and intellectual development in children, new research reports.
Alexza Pharmaceuticals, Inc. today announced that it has entered into definitive agreements with a select group of institutional investors to raise approximately $18.0 million in gross proceeds in a registered direct offering through the sale of common stock and warrants. The Company agreed to sell a total of 6,685,183 units, each unit consisting of (i) one share of common stock and (ii) one warrant to purchase 0.5 of a share of common stock, at a purchase price of $2.70 per unit.
An old pharmaceutical product may be a new treatment for obstructive sleep apnea, according to new research presented today by University of Illinois at Chicago and Northwestern University scientists at the SLEEP 2017 annual meeting in Boston.
Researchers have discovered 10 new molecular structures with pharmaceutical potential in a species of red seaweed that lives in the shallow coral reef along the coastline of Fiji in the south Pacific Ocean.
Women who take antipsychotic medication during pregnancy may be at an increased risk for developing gestational diabetes, report researchers.
› Verified 7 days ago
| Entity Name | Baptist Health Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1740586213 PECOS PAC ID: 5597867184 Enrollment ID: O20070228000503 |
News Archive
Mutations in a gene associated with leukaemia cause a newly described condition that affects growth and intellectual development in children, new research reports.
Alexza Pharmaceuticals, Inc. today announced that it has entered into definitive agreements with a select group of institutional investors to raise approximately $18.0 million in gross proceeds in a registered direct offering through the sale of common stock and warrants. The Company agreed to sell a total of 6,685,183 units, each unit consisting of (i) one share of common stock and (ii) one warrant to purchase 0.5 of a share of common stock, at a purchase price of $2.70 per unit.
An old pharmaceutical product may be a new treatment for obstructive sleep apnea, according to new research presented today by University of Illinois at Chicago and Northwestern University scientists at the SLEEP 2017 annual meeting in Boston.
Researchers have discovered 10 new molecular structures with pharmaceutical potential in a species of red seaweed that lives in the shallow coral reef along the coastline of Fiji in the south Pacific Ocean.
Women who take antipsychotic medication during pregnancy may be at an increased risk for developing gestational diabetes, report researchers.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Joshua Wallace French, MD 101 Markleham Pl, Louisville, KY 40245-4065 Ph: (502) 345-4710 | Joshua Wallace French, MD 1025 New Moody Ln, La Grange, KY 40031-9154 Ph: (502) 222-5388 |
News Archive
Mutations in a gene associated with leukaemia cause a newly described condition that affects growth and intellectual development in children, new research reports.
Alexza Pharmaceuticals, Inc. today announced that it has entered into definitive agreements with a select group of institutional investors to raise approximately $18.0 million in gross proceeds in a registered direct offering through the sale of common stock and warrants. The Company agreed to sell a total of 6,685,183 units, each unit consisting of (i) one share of common stock and (ii) one warrant to purchase 0.5 of a share of common stock, at a purchase price of $2.70 per unit.
An old pharmaceutical product may be a new treatment for obstructive sleep apnea, according to new research presented today by University of Illinois at Chicago and Northwestern University scientists at the SLEEP 2017 annual meeting in Boston.
Researchers have discovered 10 new molecular structures with pharmaceutical potential in a species of red seaweed that lives in the shallow coral reef along the coastline of Fiji in the south Pacific Ocean.
Women who take antipsychotic medication during pregnancy may be at an increased risk for developing gestational diabetes, report researchers.
› Verified 7 days ago
Dr. Timothy G Price, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1025 New Moody Ln, La Grange, KY 40031 Phone: 502-222-3347 | |
Dr. Steven D Skaggs, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1025 New Moody Ln, La Grange, KY 40031 Phone: 502-222-3347 | |
Dr. Michael R Lawrence, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1025 New Moody Ln, La Grange, KY 40031 Phone: 502-222-3347 Fax: 502-222-3634 | |
Sandra Lynn Savage, DO Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 1006 New Moody Ln Fl 1, La Grange, KY 40031 Phone: 502-222-0028 | |
Dr. Ricky L Rowe, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1025 New Moody Ln, La Grange, KY 40031 Phone: 502-222-3347 Fax: 502-222-3634 | |
Dr. Ronald L Crafton, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1025 New Moody Ln, La Grange, KY 40031 Phone: 502-222-3347 Fax: 502-222-3634 |